drug safety

Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation.

Ignota Labs is using artificial intelligence to revive shelved drug candidates, reduce clinical risk, and cut carbon emissions.

A domain-specific AI platform enables scientists to generate and test hypotheses faster, helping pharma teams reduce target prioritization timelines from weeks to days.

FDA rejections and safety concerns, a once-monthly HIV PrEP pill, developments in neuroscience drug development, and more led the news this week.

Advanced analytical techniques are making it easier to detect and measure mirror-image drug molecules that can behave very differently in the body.

Learn how to catch drugs’ hidden cardiotoxicity risks early in their development.